A recent study has identified nicotinamide phosphoribosyltransferase (NAMPT), which facilitates the biosynthesis of nicotinamide adenine dinucleotide (NAD+), as a metabolic checkpoint of CD4+ T cells in lupus nephritis for its prominent pro-inflammatory. This evidence concerns the gene NAMPT and lupus nephritis.